Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2010

Conditions
Systemic Arterial HypertensionHypertension Resistant to Conventional TherapyMyocardial InfarctionStroke
Interventions
DRUG

Anti-hypertensive drug treatment

Anti-hypertensive drug treatment was non-investigational. Drug regimen, including which drug and the number of drugs prescribed, was left at discretion of the physician who carried primary assistance.

Trial Locations (1)

22240-006

Instituto Nacional de Cardiologia, Rio de Janeiro

All Listed Sponsors
collaborator

Instituto Nacional de Cardiologia de Laranjeiras

OTHER

lead

Universidade Gama Filho

OTHER

NCT01173029 - Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events | Biotech Hunter | Biotech Hunter